Motive Wealth Advisors Acquires New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Motive Wealth Advisors bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 430 shares of the medical equipment provider’s stock, valued at approximately $224,000.

Other institutional investors have also modified their holdings of the company. Cornerstone Wealth Management LLC raised its stake in Intuitive Surgical by 4.8% in the fourth quarter. Cornerstone Wealth Management LLC now owns 550 shares of the medical equipment provider’s stock worth $287,000 after buying an additional 25 shares in the last quarter. Brighton Jones LLC boosted its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Conway Capital Management Inc. raised its holdings in Intuitive Surgical by 8.4% in the fourth quarter. Conway Capital Management Inc. now owns 4,951 shares of the medical equipment provider’s stock worth $2,584,000 after purchasing an additional 382 shares in the last quarter. FCG Investment Co lifted its position in shares of Intuitive Surgical by 9.9% during the fourth quarter. FCG Investment Co now owns 2,362 shares of the medical equipment provider’s stock valued at $1,233,000 after buying an additional 212 shares during the last quarter. Finally, Galvin Gaustad & Stein LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $218,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently commented on ISRG. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday. Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Mizuho increased their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Leerink Partners boosted their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $559.72.

Intuitive Surgical Stock Down 0.3 %

NASDAQ:ISRG opened at $608.66 on Friday. Intuitive Surgical, Inc. has a 52 week low of $362.14 and a 52 week high of $616.00. The stock’s 50-day moving average price is $544.61 and its 200-day moving average price is $502.64. The stock has a market capitalization of $216.79 billion, a PE ratio of 97.86, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 42,475 shares of company stock valued at $22,070,807. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.